Humana
782 hedge funds and large institutions have $39.1B invested in Humana in 2020 Q1 according to their latest regulatory filings, with 104 funds opening new positions, 247 increasing their positions, 326 reducing their positions, and 121 closing their positions.
0.5% more ownership
Funds ownership: 93.97% → 94.47% (+0.5%)
8% less call options, than puts
Call options by funds: $451M | Put options by funds: $491M
3% less funds holding
Funds holding: 809 → 782 (-27)
4% less funds holding in top 10
Funds holding in top 10: 25 → 24 (-1)
14% less first-time investments, than exits
New positions opened: 104 | Existing positions closed: 121
14% less capital invested
Capital invested by funds: $45.6B → $39.1B (-$6.48B)
24% less repeat investments, than reductions
Existing positions increased: 247 | Existing positions reduced: 326
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$2.57B |
| 2 |
Jennison Associates
New York
|
+$354M |
| 3 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
+$233M |
| 4 |
Renaissance Technologies
New York
|
+$195M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$184M |
Top Sellers
HUM Hedge Fund Activity: Q1 2020 in Review
782 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Humana (HUM) for Q1 2020, worth a combined $39.1B — down 14% from $45.6B a quarter earlier.
Sellers outnumbered buyers: 121 funds closed out of HUM and 104 opened new positions — a net loss of 17 holders — while 326 trimmed existing stakes and 247 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $2.57B. The largest seller was Capital Research Global Investors, cutting an estimated $1.39B.
- 782 institutional investors held Humana (HUM) as of Q1 2020, down from 809 in Q4 2019.
- Funds reported $39.1B of Humana stock for Q1 2020, down 14% quarter-over-quarter.
- 104 funds opened new Humana positions in Q1 2020 and 121 closed out, a net change of -17 holders.
- The largest Humana buyer in Q1 2020 was T. Rowe Price Associates, an estimated $2.57B added.
- The largest Humana seller in Q1 2020 was Capital Research Global Investors, an estimated $1.39B sold.
Based on aggregated 13F filings for Q1 2020.